Education
About Us
Working with TipRanks
Follow Us
REPRO-MED Systems (KRMD)
NASDAQ:KRMD
Earnings Data
Report Date
Aug 06, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
-0.02Last Year’s EPS
-0.01Same Quarter Last Year
Strong Buy
Based on 4 Analysts Ratings
Earnings Call Summary
Earnings Call Date:May 07, 2025
|% Change Since: 0.00%
|Next Earnings Date:Aug 06, 2025
Earnings Call Sentiment|Positive
KORU Medical Systems reported strong growth across its core and international business segments, leading to record revenues and an improved gross margin. The company raised its revenue guidance for 2025, demonstrating confidence in continued growth. Despite some challenges in clinical trials revenue and tariff impacts, the overall performance and strategic progress are positive.Company Guidance
During the call, KORU Medical Systems provided updated guidance for fiscal year 2025, reflecting a robust performance in the first quarter. The company reported a record revenue of $9.6 million for Q1, marking an 18% increase compared to the previous year. This growth was driven by a 21% increase in their core business, attributed to recurring revenue, new patient starts, and increased market share. As a result, KORU raised its full-year revenue guidance to a range of $38.5 million to $39.5 million, representing a year-over-year growth of 15% to 17%. The company also reaffirmed its gross margin target of 61% to 63% and expects to generate positive cash flow from operations in 2025. Additionally, they plan to submit two more drugs for 510(k) clearance by the end of the year, expanding their pipeline to five planned submissions.Record Revenue Growth
KORU Medical Systems achieved a record revenue of $9.6 million for the first quarter of 2025, representing an 18% increase over the prior year.
Core Business Expansion
The core business grew 21% in the quarter, driven by new patient starts, increased market share, and deeper penetration into new and existing geographies.
International Growth
International business achieved 36% growth, driven by patient growth and new distributor relationships in the Middle East and North Africa.
Gross Margin Improvement
Reported gross margin improved by 50 basis points to 62.8% compared to the previous year.
Raised 2025 Revenue Guidance
The company raised its 2025 revenue guidance to a range of $38.5 million to $39.5 million, representing a 15% to 17% year-over-year growth.
Pipeline Expansion
Plans to submit two additional commercialized drugs for 510(k) clearance for the Freedom Infusion System by the end of 2025, bringing the total pipeline to five planned submissions.
Positive Cash Flow Expectation
The company expects to generate positive cash flow from operations in 2025.
Prefilled Syringe Tender Win
Secured a key prefilled syringe tender win with a major pharmaceutical partner in the EU, marking a significant milestone.
KRMD Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
KRMD Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 07, 2025 | $2.72 | $3.29 | +20.96% |
Mar 12, 2025 | $3.28 | $2.70 | -17.68% |
Nov 13, 2024 | $3.20 | $3.08 | -3.75% |
Aug 07, 2024 | $2.13 | $2.48 | +16.43% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does REPRO-MED Systems (KRMD) report earnings?
REPRO-MED Systems (KRMD) is schdueled to report earning on Aug 06, 2025, TBA Not Confirmed.
What is REPRO-MED Systems (KRMD) earnings time?
REPRO-MED Systems (KRMD) earnings time is at Aug 06, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is KRMD EPS forecast?
KRMD EPS forecast for the fiscal quarter 2025 (Q2) is -0.02.